These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2882363)

  • 21. Effectiveness and pharmacokinetics of indomethacin in premature newborns with patent ductus arteriosus.
    Vert P; Bianchetti G; Marchal F; Monin P; Morselli PL
    Eur J Clin Pharmacol; 1980 Jul; 18(1):83-8. PubMed ID: 7398752
    [No Abstract]   [Full Text] [Related]  

  • 22. Plasma indomethacin levels in preterm newborn infants with symptomatic patent ductus arteriosus--clinical and echocardiographic assessments of response.
    Alpert BS; Lewins MJ; Rowland DW; Grant MJ; Olley PM; Soldin SJ; Swyer PR; Coceani F; Rowe RD
    J Pediatr; 1979 Oct; 95(4):578-82. PubMed ID: 480038
    [No Abstract]   [Full Text] [Related]  

  • 23. [Indomethacin for closure of persisting ductus arteriosus in the premature infant].
    Linderkamp O; Versmold HT
    Monatsschr Kinderheilkd; 1981 Feb; 129(2):118-20. PubMed ID: 6112670
    [No Abstract]   [Full Text] [Related]  

  • 24. Indomethacin for closure of patent ductus arteriosus in preterm neonates.
    Nair PA; Karan S
    Indian J Pediatr; 1986; 53(4):499-503. PubMed ID: 3804391
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of echocardiography to guide the duration of indomethacin treatment of patent ductus arteriosus in preterm infants.
    Bajaj R; Narasimhan R
    J Pediatr; 2010 Aug; 157(2):346; author reply 346. PubMed ID: 20553839
    [No Abstract]   [Full Text] [Related]  

  • 26. Indomethacin for closure of patent ductus arteriosus in prematures.
    Mullett MD; Croghan TW; Myerberg DZ; Krall JM; Neal WA
    Clin Pediatr (Phila); 1982 Apr; 21(4):217-20. PubMed ID: 7039927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of an aneurysmal dilatation of the ductus arteriosus with indomethacin in a premature infant.
    Doege C; Linderkamp O; Gorenflo M; Bauer J
    Pediatr Cardiol; 2006; 27(1):166-167. PubMed ID: 16261270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Indomethacin therapy of patent ductus in preterm infants controlled by plasma levels.
    Lewis IG; Harvey DP; Maxwell GM
    Aust Paediatr J; 1985 Aug; 21(3):181-3. PubMed ID: 4062716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prophylactic indomethacin therapy for patent ductus arteriosus in very-low-birth-weight infants.
    Mahony L; Carnero V; Brett C; Heymann MA; Clyman RI
    N Engl J Med; 1982 Mar; 306(9):506-10. PubMed ID: 7035955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous indomethacin therapy in premature infants with patent ductus arteriosus. Causes of death and one-year follow-up.
    Yeh TF; Goldbarg HR; Henek T; Thalji A; Pildes RS
    Am J Dis Child; 1982 Sep; 136(9):803-7. PubMed ID: 7114004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early indomethacin in patent ductus of the very small premature.
    Burnard ED; Thomas DB; Grattan-Smith P
    Aust Paediatr J; 1982 Mar; 18(1):28-31. PubMed ID: 7103877
    [No Abstract]   [Full Text] [Related]  

  • 32. [Progresses in treatment of patent ductus arteriosus in premature infants].
    Zhang CC; Cheng GQ
    Zhonghua Er Ke Za Zhi; 2012 Nov; 50(11):871-3. PubMed ID: 23302624
    [No Abstract]   [Full Text] [Related]  

  • 33. Indomethacin for preterm infants with intracranial hemorrhage.
    Chiba H; Masutani S; Toyoshima K; Mori R
    Pediatr Int; 2013 Feb; 55(1):124-6. PubMed ID: 23409994
    [No Abstract]   [Full Text] [Related]  

  • 34. The management of symptomatic patient ductus arteriosus in premature infants.
    Ho LY
    J Singapore Paediatr Soc; 1986; 28(1-2):153-62. PubMed ID: 3762074
    [No Abstract]   [Full Text] [Related]  

  • 35. Persistent Doppler flow predicts lack of response to multiple courses of indomethacin in premature infants with recurrent patent ductus arteriosus.
    Keller RL; Clyman RI
    Pediatrics; 2003 Sep; 112(3 Pt 1):583-7. PubMed ID: 12949288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacologic closure of patent ductus arteriosus in the premature infant.
    Friedman WF; Hirschklau MJ; Printz MP; Pitlick PT; Kirkpatrick SE
    N Engl J Med; 1976 Sep; 295(10):526-9. PubMed ID: 820994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of patent ductus arteriosus in preterm infants].
    Jaso E; Tejedor JC; Quero J; Pérez Rodríguez J; Agustí B; Castro J; García Frías E
    An Esp Pediatr; 1982 Jun; 16(6):449-58. PubMed ID: 7125398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ibuprofen and patent ductus arteriosus.
    Clyman RI
    N Engl J Med; 2000 Sep; 343(10):728-30. PubMed ID: 10974138
    [No Abstract]   [Full Text] [Related]  

  • 39. Patent ductus arteriosus in premature infants: a review of current management.
    Neal WA; Mullett MD
    Pediatr Cardiol; 1982; 3(1):59-63. PubMed ID: 7155941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased plasma glucose after indomethacin therapy in premature infants with patent ductus anteriosus.
    Yeh TF; Raval D; Lilien LD; Srinivasan G; Pildes RS
    Lancet; 1982 Jul; 2(8289):104-5. PubMed ID: 6123794
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.